Lasa Supergenerics: Certificate under SEBI (Depositories and Participants) Regulations, 2018 for Q4FY26
Lasa Supergenerics Limited submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended March 31, 2026. The RTA confirmed dematerialization processing and cancellation of certificates.
This is a standard regulatory compliance filing and has no immediate material impact on the company's operations or stock performance.
The announcement is a routine compliance filing regarding the processing of securities for dematerialization and does not contain any financial or operational performance updates.
Lasa Supergenerics Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter and the financial year ended March 31, 2026.
The certificate was received from Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent. Bigshare Services confirmed that securities received for dematerialization up to March 31, 2026, were processed and confirmed with the depositories. They also stated that the security certificates received for dematerialization were duly verified, mutilated, and cancelled, with the depositories' names substituted in the register of members within the stipulated 15-day period.
The company has requested that this information be noted in the records of BSE Limited and the National Stock Exchange of India Limited.
What to do with a filing like this
Lasa Supergenerics Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lasa Supergenerics Limited. Read the original for the full detail.